Arrive AI Bolsters Its Team with 2 World-class Additions
Former Elevance Health CFO John Gallina and former Carmel, Ind. Mayor Jim Brainard add international heft to company leadership INDIANAPOLIS,...
Month: August 2024
Professional Drummer Mark Schulman Shifts into a New Career – and Better Hearing, Thanks to Widex SmartRIC™ Hearing Aids
HAUPPAUGE, N.Y., Aug. 5, 2024 /PRNewswire/ -- Mark Schulman has toured as a professional drummer with some of the biggest artists...
OpenLoop Health Invests in AI Technology and Makes Strategic Expansions in First Half of 2024
DES MOINES, Iowa, Aug. 5, 2024 /PRNewswire/ -- OpenLoop Health, a national leader in white-label telehealth support services, expands into...
Globalmed® Announces Abbie Forster as New Clinical Director
SCOTTSDALE, Ariz., Aug. 5, 2024 /PRNewswire/ -- GlobalMed®, the leading voice in the world of telehealth and virtual medicine, is...
Timken to Expand Motion-Control Platform, Capabilities with Acquisition of CGI Inc.
Addition will create unmatched portfolio of precision drives NORTH CANTON, Ohio, Aug. 5, 2024 /PRNewswire/ -- The Timken Company (NYSE:...
CareAbout Health Appoints New Chief Technology Officer
NEW YORK, Aug. 5, 2024 /PRNewswire/ -- CareAbout Health, a leading healthcare management company, today announced the appointment of Masoud Nourmohammadi...
Jaguar Health Issues Shareholder Letter: Company to Explore Approval Pathway for Crofelemer in Breast and Lung Cancer Based on Phase 3 Results – Investor Webcast August 13th Will Review Q2 Earnings and Further Review OnTarget Trial’s Clinically Meaningful Results
In 2022 breast cancer was the most common cancer in women in 157 countries out of 185, and lung cancer...
Vascular Therapies Completes Enrollment in the ACCESS 2 Study, a Phase III Multinational Randomized Clinical Trial of the Sirolimus Eluting Collagen Implant (Sirogen) for the Surgical Creation of Arteriovenous Fistula for Hemodialysis Vascular Access
- Trial will evaluate the effectiveness of perivascular sirolimus to improve AV Fistula outcomes in patients with kidney disease --...
Transforming Aesthetics: Dr. Maria Fedchuk’s Journey of Innovation at MTS US
The 22nd Aesthetic & Anti-Aging Medicine World Congress held in Monaco, Monte-Carlo, witnessed a significant event in the realm of...
IntoValue, Inc, Welcomes Steve Nelson to Board of Directors
IntoValue, Inc., a groundbreaking healthcare direct-to-employer technology enablement company, proudly announces the appointment of Steve Nelson to its Board of...
Latino Community Fund (LCF Georgia) Announces ‘Estamos Aquí Fiesta’ to Kick Off Hispanic/Latinx Heritage Month
"Estamos Aquí Fiesta 2024": Celebrating Hispanic Heritage Month with an Exciting Lineup from the Latino Community Fund GeorgiaATLANTA, GA /...
Dr. Xieng Lee, DDS is Featured in an Exclusive Interview with Infinite Sights
Dr. Xieng Lee, DDS a renowned dentist and community advocate based at Quality Dental Care in Brooklyn Park, MN, was...
BIO-Europe(R) Celebrates 30th Anniversary with Landmark Event in Stockholm
MUNICH, GERMANY / ACCESSWIRE / August 5, 2024 / Join the 30th anniversary edition of BIO-Europe®, the premier biopharma partnering...
Avinger Appoints Thomas P. Davis, MD, FACC as Chief Medical Officer
REDWOOD CITY, CA / ACCESSWIRE / August 5, 2024 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company marketing the...
AFB Names 2024 Migel Medal Honorees
WASHINGTON, Aug. 05, 2024 (GLOBE NEWSWIRE) -- The American Foundation for the Blind (AFB) has announced that Kim Charlson and...
Safety Shot to Release On-the-Go Powder Stick Packs of the World’s First Alcohol Reducing Product
With an Expected Launch in Early Q4, Safety Shot Powder Stick Packets Will Address an Anticipated $517M Market Size JUPITER,...
Onco360® Has Been Selected as a National Specialty Pharmacy for crovalimab-akkz
LOUISVILLE, Ky., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected by Genentech,...
Excision BioTherapeutics Awarded a “Fierce 15” Biotech Company of 2024
Company Applying its Proprietary CRISPR Technology to Address Recurrent Infections in Herpes Simplex Keratitis (HSK)HSK is the Leading Cause of...
Senti Bio Announces Execution of Grant Award from California Institute for Regenerative Medicines (CIRM) for Clinical Development of SENTI-202
SOUTH SAN FRANCISCO, Calif., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a biotechnology company...
TRxADE Health, Inc. Announces New Addition and Changes to Scienture, LLC’s Executive Leadership Team
TAMPA, FL and COMMACK, NY, Aug. 05, 2024 (GLOBE NEWSWIRE) -- TRxADE Health, Inc. (“TRxADE”) (NASDAQ: MEDS) and Scienture, LLC...